| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | Aug 20, 2024 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $75.08 | $1M | -38.65% |
| Mar 07, 2024 | Mar 12, 2024 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $66.23 | $1M | -40.81% |
| Feb 26, 2024 | Feb 28, 2024 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $70.13 | $554,491 | -21.03% |
| Feb 02, 2024 | Feb 05, 2024 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $67.15 | $796,367 | -28.54% |
| Nov 06, 2023 | Nov 08, 2023 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $55.63 | $2M | -58.80% |
| Aug 07, 2023 | Aug 09, 2023 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $58.79 | $3M | -54.95% |
| Mar 28, 2023 | Mar 30, 2023 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $54.31 | $847,380 | -25.60% |
| Mar 10, 2023 | Mar 13, 2023 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $43.84 | $539,599 | -16.80% |
| Mar 01, 2023 | Mar 04, 2023 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $50.01 | $362,122 | -12.83% |
| Feb 24, 2023 | Feb 28, 2023 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $47.12 | $190,648 | -6.69% |
| Feb 21, 2023 | Feb 23, 2023 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $47.01 | $183,246 | -6.90% |
| Apr 08, 2022 | Apr 08, 2022 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $64.37 | $6M | -65.57% |
| Feb 24, 2022 | Feb 26, 2022 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $52.21 | $412,810 | -14.85% |
| Feb 22, 2022 | Feb 24, 2022 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $55.29 | $615,827 | -19.72% |
| Jan 10, 2022 | Jan 12, 2022 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $40.78 | $854,255 | -31.60% |
| Oct 18, 2021 | Oct 19, 2021 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $40.86 | $549,551 | -22.88% |
| Feb 19, 2021 | Feb 23, 2021 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $39.22 | $203,308 | -10.26% |
| Jan 11, 2021 | Jan 13, 2021 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $32.02 | $310,082 | -19.74% |
| Oct 16, 2020 | Oct 16, 2020 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $26.8 | $182,026 | -19.45% |
| Oct 16, 2019 | Oct 17, 2019 | Neumann Mark EVP Chief Commercial Officer | Sell | Intra-Cellular Therapies, Inc. | ITCI | $8.25 | $55,886 | -50.37% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.